Predictions
Centene Corp.
Start price
Target price
Perf. (%)
€51.00
01.05.21
01.05.21
€56.00
01.05.22
01.05.22
50.31%
02.05.22
02.05.22
Could be worthwhile Investment >10% per year
Abiomed Inc.
Start price
Target price
Perf. (%)
€238.80
07.06.21
07.06.21
€250.00
29.04.22
29.04.22
15.03%
30.04.22
30.04.22
Could be worthwhile Investment >10% per year
Abiomed Inc.
Start price
Target price
Perf. (%)
€238.80
07.06.21
07.06.21
€250.00
29.04.22
29.04.22
15.03%
30.04.22
30.04.22
Could be worthwhile Investment >10% per year
Agilent Technologies Inc.
Start price
Target price
Perf. (%)
€101.00
09.03.21
09.03.21
€120.00
09.03.22
09.03.22
19.46%
10.03.22
10.03.22
Could be worthwhile Investment >10% per year
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€463.95
25.01.21
25.01.21
€500.00
25.01.22
25.01.22
15.42%
26.01.22
26.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€463.95
25.01.21
25.01.21
€500.00
25.01.22
25.01.22
15.42%
26.01.22
26.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€463.95
25.01.21
25.01.21
€500.00
25.01.22
25.01.22
15.42%
26.01.22
26.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Biogen Inc.
Start price
Target price
Perf. (%)
€243.10
18.10.21
18.10.21
€210.00
02.01.23
02.01.23
-12.53%
16.12.21
16.12.21
Could be worthwhile Investment >10% per year
Biogen Inc.
Start price
Target price
Perf. (%)
€243.10
18.10.21
18.10.21
€210.00
02.01.23
02.01.23
-12.53%
16.12.21
16.12.21
Could be worthwhile Investment >10% per year
Biogen Inc.
Start price
Target price
Perf. (%)
€243.10
18.10.21
18.10.21
€210.00
02.01.23
02.01.23
-12.53%
16.12.21
16.12.21
Could be worthwhile Investment >10% per year
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€442.80
23.11.20
23.11.20
€555.00
23.11.21
23.11.21
29.97%
24.11.21
24.11.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€442.80
23.11.20
23.11.20
€555.00
23.11.21
23.11.21
29.97%
24.11.21
24.11.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€442.80
23.11.20
23.11.20
€555.00
23.11.21
23.11.21
29.97%
24.11.21
24.11.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€529.00
22.11.20
22.11.20
€500.00
22.11.21
22.11.21
7.75%
23.11.21
23.11.21
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€529.00
22.11.20
22.11.20
€500.00
22.11.21
22.11.21
7.75%
23.11.21
23.11.21
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€529.00
22.11.20
22.11.20
€500.00
22.11.21
22.11.21
7.75%
23.11.21
23.11.21
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€131.66
06.06.20
06.06.20
€205.00
04.11.21
04.11.21
77.81%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Pfizer Inc.
Start price
Target price
Perf. (%)
€27.04
17.03.20
17.03.20
€33.21
04.11.21
04.11.21
47.75%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Pfizer Inc.
Start price
Target price
Perf. (%)
€27.04
17.03.20
17.03.20
€33.21
04.11.21
04.11.21
47.75%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year